|
FUT11 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.081000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.347600E-01 |
| Normal-vs-Stage2 |
7.284000E-01 |
| Normal-vs-Stage3 |
6.875600E-01 |
| Normal-vs-Stage4 |
8.236400E-01 |
| Stage1-vs-Stage2 |
5.020400E-01 |
| Stage1-vs-Stage3 |
9.295200E-01 |
| Stage1-vs-Stage4 |
9.565200E-01 |
| Stage2-vs-Stage3 |
5.812400E-01 |
| Stage2-vs-Stage4 |
7.207200E-01 |
| Stage3-vs-Stage4 |
9.985800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.677400E-01 |
| Normal-vs-AfricanAmerican |
9.796800E-01 |
| Normal-vs-Asian |
6.099900E-02 |
| Caucasian-vs-AfricanAmerican |
3.939000E-01 |
| Caucasian-vs-Asian |
2.073600E-02 |
| AfricanAmerican-vs-Asian |
3.068800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.665000E-01 |
| Normal-vs-Female |
2.132100E-02 |
| Male-vs-Female |
1.476470E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.388000E-01 |
| Normal-vs-Extreme_Weight |
7.196800E-01 |
| Normal-vs-Obese |
1.470160E-01 |
| Normal-vs-Extreme_Obese |
6.940800E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.491400E-01 |
| Normal_Weight-vs-Obese |
2.389800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.924000E-01 |
| Extreme_Weight-vs-Obese |
1.045840E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.650200E-01 |
| Obese-vs-Extreme_Obese |
3.311000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.480000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.432400E-02 |
| Normal-vs-Age(61-80Yrs) |
7.931800E-01 |
| Normal-vs-Age(81-100Yrs) |
7.262300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.076000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.132400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.098200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.573920E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.449000E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.727910E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.564400E-01 |
| Normal-VS-Type2 PRCC |
4.083600E-01 |
| Normal-VS-KIRP CIMP |
1.644610E-01 |
| Normal-VS-Unclassified PRCC |
7.087900E-02 |
| Type1 PRCC-VS-Type2 PRCC |
9.682200E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.022200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.050800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.634400E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.400420E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.192200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.638400E-01 |
| Normal-vs-N1 |
6.531400E-01 |
| Normal-vs-N2 |
6.174600E-01 |
| N0-vs-N1 |
3.579200E-01 |
| N0-vs-N2 |
2.542600E-01 |
| N1-vs-N2 |
5.243200E-01 |
|
|
